Time for definitions to breakthrough from the background?
作者信息
Rastogi Sachin
机构信息
Department of Anaesthesia, Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, UK.
出版信息
Br J Pain. 2024 Jun;18(3):212-214. doi: 10.1177/20494637241250270. Epub 2024 Apr 23.
Abstract
摘要
相似文献
1
Time for definitions to breakthrough from the background?
Br J Pain. 2024 Jun;18(3):212-214. doi: 10.1177/20494637241250270. Epub 2024 Apr 23.
2
A rapid systematic review of breakthrough pain definitions and descriptions.
Br J Pain. 2024 Jun;18(3):215-226. doi: 10.1177/20494637231208093. Epub 2023 Dec 25.
3
Defining breakthrough invasive fungal infection-Position paper of the mycoses study group education and research consortium and the European Confederation of Medical Mycology.
Mycoses. 2019 Sep;62(9):716-729. doi: 10.1111/myc.12960. Epub 2019 Jul 19.
4
Permeation tests of glove and clothing materials against sensitizing chemicals using diphenylmethane diisocyanate as an example.
Ann Occup Hyg. 2014 Aug;58(7):921-30. doi: 10.1093/annhyg/meu040. Epub 2014 Jun 16.
5
Breakthrough cancer pain: review of prevalence, characteristics and management.
Indian J Palliat Care. 2009 Jan;15(1):14-8. doi: 10.4103/0973-1075.53506.
6
Lean Management and Breakthrough Performance Improvement in Health Care.
Qual Manag Health Care. 2021;30(1):6-12. doi: 10.1097/QMH.0000000000000282.
7
[Research progress on breakthrough cases of vaccine-preventable diseases].
Zhonghua Yu Fang Yi Xue Za Zhi. 2025 Apr 6;59(4):535-541. doi: 10.3760/cma.j.cn112150-20240523-00418.
8
Definitions of breakthrough disease and second-line agents.
Neurol Clin. 2011 May;29(2):411-22. doi: 10.1016/j.ncl.2010.12.005.
9
Assessment and classification of cancer breakthrough pain: a systematic literature review.
Pain. 2010 Jun;149(3):476-482. doi: 10.1016/j.pain.2010.02.035. Epub 2010 Mar 16.
10
Changes in the epidemiology of invasive fungal disease in a Pediatric Hematology and Oncology Unit: the relevance of breakthrough infections.
BMC Infect Dis. 2023 May 25;23(1):348. doi: 10.1186/s12879-023-08314-9.
本文引用的文献
1
Development of a Screening Tool for Pediatric Neuropathic Pain and Complex Regional Pain Syndrome: Pediatric PainSCAN.
Clin J Pain. 2021 Oct 12;38(1):15-22. doi: 10.1097/AJP.0000000000000993.
2
The Modified WHO Analgesic Ladder: Is It Appropriate for Chronic Non-Cancer Pain?
J Pain Res. 2020 Feb 17;13:411-417. doi: 10.2147/JPR.S244173. eCollection 2020.
3
Evaluation of Quality of Life and Satisfaction of Patients with Neuropathic Pain and Breakthrough Pain: Economic Impact Based on Quality of Life.
Pain Res Treat. 2018 Sep 5;2018:5394021. doi: 10.1155/2018/5394021. eCollection 2018.
4
From "Breakthrough" to "Episodic" Cancer Pain? A European Association for Palliative Care Research Network Expert Delphi Survey Toward a Common Terminology and Classification of Transient Cancer Pain Exacerbations.
J Pain Symptom Manage. 2016 Jun;51(6):1013-9. doi: 10.1016/j.jpainsymman.2015.12.329. Epub 2016 Feb 26.
5
Development and validation of the breakthrough pain assessment tool (BAT) in cancer patients.
J Pain Symptom Manage. 2014 Oct;48(4):619-31. doi: 10.1016/j.jpainsymman.2013.10.026. Epub 2014 Apr 22.
Zotero 插件